The risk of developing lymphoma in autoimmune diseases: a meta-analysis.
Arch Intern Med. 2005; 165: 2337-2344
Autoimmunity and lymphomagenesis.
Int J Cancer. 2009; 124: 1497-1502
Prediction of ankylosing spondylitis in HUNT studies with a genetic risk score combining 110 single-nucleotide polymorphisms of significance across the genome.
J Rheumatism. 2020; 47: 204-210
Identification of multiple risk variants for ankylosing spondylitis by high-density genotyping of immune-related loci.
Nat June. 2013; 45: 730-738
Common genetic background of inflammatory bowel disease and ankylosing spondylitis: A genealogical study in Iceland.
Arthritic rheumatism. 2007; 56: 2633-2639
HLA-B27-associated arthritis and intestinal inflammation, Part 2: Ilecolonoscopy and intestinal histology in patients with HLA-B27-associated arthritis.
J Rheumatism. 1985; 12: 294-298
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.
lancet. 2009; 374: 1617-1625
Lymphoma risk factors in patients with inflammatory bowel disease: a case-control study.
Inflammatory bowel disease. 2013; 19: 1384-1389
Extraintestinal cancer risk in inflammatory bowel disease: a meta-analysis of population-based cohort studies.
J digestive system. 2010; 105: 1480-1487
Cancer incidence in patients with ankylosing spondylitis in Sweden from 1965 to 1995: a population-based cohort study.
An Reum Dis. 2003; 62: 1185-1188
Lymphoma history and risk: results of a population-based case-control study in Germany.
Eur J Cancer. 2005; 41: 133-142
Risk of malignant lymphoma in ankylosing spondylitis: a Swedish national case-control study.
An Reum Dis. 2006; 65: 1184-1187
Autoimmunity and susceptibility to Hodgkin’s lymphoma: a population-based case-control study in Scandinavia.
J National Cancer Institute. 2006; 98: 1321-1330
Familial features of autoimmune and hematological disorders in 8,406 patients with multiple myeloma: a population-based case-control study.
Int J Cancer. 2006; 118: 3095-3098
Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries.
blood. 2006; 108: 292-296
Autoimmune disease in individuals and relatives, and susceptibility to non-Hodgkin’s lymphoma.
Arthritic rheumatism. 2008; 58: 657-666
Risk of Multiple Myeloma and Monoclonal Immunoglobulinemia of Undetermined Significance Among White and Black Male U.S. Veterans With Histories of Autoimmune, Infectious, Inflammatory, and Allergic Diseases .
blood. 2008; 111: 3388-3394
Population-based studies of autoimmune conditions and risk of certain lymphoid malignancies.
Int J Cancer. 2009; 125: 398-405
Risk of myeloid malignancies in patients with autoimmune conditions.
Br J Cancer. 2009; 100: 822-828
A personal and family history of immune-related disease increases the risk of plasma cell disorders: a population-based study.
blood. 2011; 118: 6284-6291
Impact of autoimmune disease on subsequent multiple myeloma incidence and survival.
J Hematol Oncol. 2012; Five: 59
Subsequent leukemia in patients with autoimmune disease.
Br J Hematol. 2013; 161: 677-687
Autoimmune diseases associated with non-Hodgkin’s lymphoma: a national cohort study.
Ann Ongol. 2014; twenty five: 2025-2030
Ankylosing spondylitis, psoriatic arthritis, and malignant lymphoma risk: a cohort study based on national prospective data from Sweden.
Rheumatoid arthritis. 2014; 66: 1282-1290
Hodgkin lymphoma after autoimmune disease by age at diagnosis and histologic subtype.
Ann Ongol. 2014; twenty five: 1397-1404
Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registries.
An Reum Dis. 2017; 76: 105-111
Increased cancer risk in patients with ankylosing spondylitis: a national population-based retrospective cohort study.
Scan J Rheumatism. 2014; 43: 301-306
Ankylosing spondylitis and cancer risk.
on corlette. 2017; 14: 1315-1322
Cancer risk in patients with ankylosing spondylitis: a national cohort study from Taiwan.
Scan J Rheumatism. 2021; 50: 132-138
Malignant risk in Korean male patients with ankylosing spondylitis.
Rheumatism International. 2019; 39: 1741-1748
Epidemiology and etiology of leukemia and lymphoma.
Cold Spring Herb Perspective Med. 2020; Ten: a034819
Time trends in incidence and survival rates for all leukemia types in the United States from 1975 to 2017.
J cancer. 2021; 12: 2326-2335
Epidemiology of Axial Spondyloarthritis: An Update.
Curr Opin rheumatism. 2018; 30: 137-143
Validity of ankylosing spondylitis diagnosis in The Health Improvement Network.
Pharmacoepidemiol Drug Saf. 2016; twenty five: 399-404
Validation of an algorithm in multiple myeloma based on administrative data using the SEER tumor registry and medical record review.
Pharmacoepidemiol Drug Saf. 2019; 28: 256-263
The Medicare Modernization Act of 2003 and its association with patient wait times and travel distances for chemotherapy.
jam. 2008; 300: 189-196
Concordance of diagnoses and dates of hematological malignancies and solid tumors between Medicare claims and cancer registry data.
Cancer causes control. 2007; 18: 561-569
April 15, 2020 ()
Accuracy of diagnosis of inflammatory arthritis in the managed hospitalization database.
Pharmacoepidemiol Drug Saf. 2021; 30: 257-265
Cancer in geriatric-onset inflammatory bowel disease: a population-based study.
J digestive system. 2016; 111: 1428-1436
Cancer risk in patients with inflammatory bowel disease: a population-based study.
cancer. 2001; 91: 854-862
Use of nonsteroidal anti-inflammatory drugs and risk of non-Hodgkin’s lymphoma: a systematic review and meta-analysis.
Hematol Oncol. 2015; 33: 176-186
Aspirin and other nonsteroidal anti-inflammatory drugs, statins, and the risk of non-Hodgkin’s lymphoma.
Int J Cancer. 2021; 149: 535-545
Ankylosing spondylitis and monoclonal immunoglobulinemia.
An Reum Dis. 1992; 51: 951-954
Spondyloarthritis and monoclonal immunoglobulinemia.
Articular bone spine. 2012; 79: 327-329
Ionizing radiation as a risk factor for lymphoma: a review.
J Radiol Prot. 2020; 40: R151-R185
Trends in the use of biologics in rheumatoid arthritis patients enrolled in the U.S. Medicare program.
Arthritis Careless (Hoboken). 2013; 65: 1743-1751